EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Uterine sarcoma with KAT6B/A::KANSL1 fusion: a molecular and clinicopathological study on 9 cases

Pavel Dundr, Jiří Dvořák, Michaela Krausová, Jan Hojný, Nikola Hájková, Ivana Stružinská, Kristýna Němejcová, Ondřej Ondič, Michael Michal, Květoslava Michalová, Alberto Berjón, Marcin Jedryka und 10 weitere

Virchows Archiv · 2025-03 · 486 (3) · 551-562

DOI: 10.1007/s00428-024-03994-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Virchows Archiv, online erschienen am 04.12.2024. Verfasst von Pavel Dundr und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, Prague 2, 12800, Cze…. Hauptthemen laut MEDLINE: Uterine Neoplasms, Biomarkers, Tumor, Histone Acetyltransferases, Sarcoma. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo Zdravotnictví Ceské Republiky, Agentura Pro Zdravotnický Výzkum České Republiky, Univerzita Karlova v Praze.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uterine sarcomas with KAT6B/A::KANSL1 fusion represent a new entity characterized by bland morphology, commonly with hybrid features of low-grade endometrial stromal sarcoma (LG-ESS) and tumors with smooth muscle differentiation. In our study, we performed a detailed morphological, immunohistochemical, and molecular analysis of 9 cases of these tumors. Six of those had been originally diagnosed as LG-ESS, one as leiomyoma, one as leiomyosarcoma, and the remaining case as sarcoma with the KAT6B/A::KANSL1 fusion. Seven cases showed overlapping features between endometrial stromal and smooth muscle tumors, one case resembled cellular leiomyoma, and one case resembled high-grade endometrial stromal sarcoma. Immunohistochemically, the tumors showed a common expression of smooth muscle markers and endometrial stromal markers. Molecular findings showed the KAT6B/A::KANSL1 fusion in all cases (by NGS and FISH). In addition, mutations affecting genes such as TP53 , PDGFRB , NF1 , RB1 , PTEN , ATM , RB1, FANCD2, and TSC1 were present in all 5 cases with aggressive behavior. One patient with no evidence of disease showed no additional mutations, while another harbored a mutation of a single gene ( ERCC3 ). Of the 8 patients with available follow-up, two died of disease, 3 are currently alive with disease, and 3 have no evidence of disease. The correct recognition of tumors with the KAT6B/A::KANSL1 fusion is essential because despite the bland morphological features of most cases, these tumors have a propensity for aggressive behavior.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine NeoplasmsBiomarkers, TumorHistone AcetyltransferasesSarcomaOncogene Proteins, FusionSarcoma, Endometrial StromalHumansFemaleMiddle AgedAdultAgedEndometrial NeoplasmsGene FusionImmunohistochemistry

Stichwörter der Autor:innen

Endometrial stromal sarcomaKAT6B/A::KANSL1 fusionNext generation sequencingUterine tumor

Substanzen

Biomarkers, TumorHistone AcetyltransferasesKAT6B protein, humanOncogene Proteins, Fusion

Autor:innen und Institutionen

  • Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, Prague 2, 12800, Czech Republic. pavel.dundr@vfn.cz.
  • Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, Prague 2, 12800, Czech Republic.
  • Department of Pathology, Charles University, Faculty of Medicine in Plzeň, Bioptical Laboratory, Ltd, Plzeň, Czech Republic.
  • Pathology Department, La Paz University Hospital, Madrid, Spain.
  • Oncology Department, Wroclaw Medical University, Wroclaw, Poland.
  • Oncological Gynecology Department, Lower Silesian Oncology, Pulmonology and Hematology Center, Wroclaw, Poland.

Förderung

  • Ministerstvo Zdravotnictví Ceské Republiky
  • Agentura Pro Zdravotnický Výzkum České Republiky
  • Univerzita Karlova v Praze
  • European Regional Development Fund
  • Charles University

Zitieren

APA

Dundr, P., Dvořák, J., Krausová, M., Hojný, J., Hájková, N., Stružinská, I., Němejcová, K., Ondič, O., Michal, M., Michalová, K., Berjón, A., Jedryka, M., Książek, M., Poprawski, T., Ryś, J., Volodko, N., Zapardiel, I., Zima, T., Cibula, D., …, & Kendall Bártů, M. (2025). Uterine sarcoma with KAT6B/A::KANSL1 fusion: a molecular and clinicopathological study on 9 cases. Virchows Archiv, 486(3), 551-562. https://doi.org/10.1007/s00428-024-03994-3

Vancouver

Dundr P, Dvořák J, Krausová M, Hojný J, Hájková N, Stružinská I, et al. Uterine sarcoma with KAT6B/A::KANSL1 fusion: a molecular and clinicopathological study on 9 cases. Virchows Archiv. 2025;486(3):551-562. doi:10.1007/s00428-024-03994-3

BibTeX
@article{Dundr2025,
  author = {Dundr, Pavel and Dvořák, Jiří and Krausová, Michaela and Hojný, Jan and Hájková, Nikola and Stružinská, Ivana and Němejcová, Kristýna and Ondič, Ondřej and Michal, Michael and Michalová, Květoslava and Berjón, Alberto and Jedryka, Marcin and Książek, Mariusz and Poprawski, Tymoteusz and Ryś, Janusz and Volodko, Nataliya and Zapardiel, Ignacio and Zima, Tomáš and Cibula, David and Poncová, Renata and Matěj, Radoslav and Kendall Bártů, Michaela},
  title = {Uterine sarcoma with KAT6B/A::KANSL1 fusion: a molecular and clinicopathological study on 9 cases},
  journal = {Virchows Archiv},
  year = {2025},
  volume = {486},
  number = {3},
  pages = {551--562},
  doi = {10.1007/s00428-024-03994-3}
}
Kostenlos starten →